ARROWHEAD PHARMACEUTICALS, INC.

Develops RNAi medicines to silence genes causing intractable cardiometabolic and pulmonary diseases.

ARWR | US

Overview

Corporate Details

ISIN(s):: US04280A1007
LEI:
Country:: United States of America
Address:: 177 E COLORADO BLVD, 91105 PASADENA
Website:: https://arrowheadpharma.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company that develops medicines to treat intractable diseases by silencing the genes that cause them. The company's core technology is its proprietary Targeted RNAi Molecule (TRiM™) platform, which utilizes RNA interference (RNAi) to induce rapid, deep, and durable suppression of specific target genes. Arrowhead's clinical pipeline is focused on a broad range of therapeutic areas, including cardiometabolic, pulmonary, neuromuscular, and liver diseases, such as hepatitis B and alpha-1 antitrypsin deficiency-associated liver disease. The company emphasizes accelerating the development of its innovative therapies from discovery to the clinic to address unmet patient needs.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all ARROWHEAD PHARMACEUTICALS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ARROWHEAD PHARMACEUTICALS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for ARROWHEAD PHARMACEUTICALS, INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
PEPTONIC Medical AB Develops clinically proven self-care products for women's intimate health.	Sweden	PMED
Peptron, Inc. Develops sustained-release peptide medicines for chronic & neurodegenerative disorders.	South Korea	087010
PERRIGO Co plc World's largest manufacturer of store-brand OTC consumer health products.	United States of America	PRGO
Perseus Proteomics Inc. Develops antibody drugs for cancer, provides research support, and sells diagnostic reagents.	Japan	4882
Personalis, Inc. Cancer genomics & liquid biopsy for early recurrence detection & guiding precision therapies.	United States of America	PSNL
Perspective Therapeutics, Inc. Developing targeted alpha radiotherapies using lead-212 to image and treat solid tumors.	United States of America	CATX
PharmAbcine Inc. Develops antibody therapies for cancer, eye diseases, and vascular-related disorders.	South Korea	208340
Pharma Foods International Co., Ltd. Researches and sells functional ingredients and direct-to-consumer health & beauty products.	Japan	2929
Pharma Mar S.A. Develops and commercializes marine-derived oncology treatments for rare cancers.	Spain	PHM
Pharmanutra Researches and markets nutritional supplements & medical devices for all ages.	Italy	PHN